phosphatidylcholines has been researched along with ginsenoside m1 in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (ginsenoside m1) | Trials (ginsenoside m1) | Recent Studies (post-2010) (ginsenoside m1) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 269 | 5 | 212 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, L; Chen, XJ; Dong, XQ; Li, MG; Liang, H; Liu, WJ; Ma, LQ; Wen, ML; Wu, SM; Zhao, JY; Zhu, YZ; Zou, CG | 1 |
| Cai, N; Jin, X; Yang, Q | 1 |
2 other study(ies) available for phosphatidylcholines and ginsenoside m1
| Article | Year |
|---|---|
Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Ginsenosides; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Rats; Tissue Inhibitor of Metalloproteinase-1 | 2017 |
Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Drug Delivery Systems; Ginsenosides; Humans; Lung Neoplasms; Male; Mice, Nude; Micelles; Optical Imaging; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Tumor Burden; Wound Healing | 2018 |